Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Effect of bisphosphonates on muscle in Duchenne muscular dystrophy
FY 2015-16
Summary
Duchenne muscular dystrophy (DMD) is a fatal, X-linked recessive disease that affects 1 in 3500 boys. Genetic mutations in the protein dystrophin destabilize the muscle and causes muscle inflammation and degradation. Boys with DMD gradually lose muscle function and become dependent on wheelchairs and ventilators for day-to-day function; they often succumb to the disease in their twenties.In addition to muscle loss, patients also have bone problems, such as fractures. This is due to decreased a lack of physical activity, increased inflammation, and use of drug treatments to retain muscle use. Bisphosphonates (BPs) are given to patients at risk for bone fractures. Previous studies a DMD mouse model found that BP treatment improved muscle strength and decreased markers of muscle degradation; BP-treated mice also have lower markers of ongoing muscle repair, suggesting that fewer muscle fibres were damaged and underwent regeneration. Overall, these observations suggest that BPs are beneficial to muscle in a DMD model. It is unknown how BP treatment is causing such changes, and clarifying its effects can provide new insight into additional treatments for muscle damage.This study will characterize the timeline of BP effects on muscle damage and clarify how BP affects muscle degeneration by histology and gene expression analysis. Pamidronate is chosen as it is effective in pediatric populations. We will use pamidronate doses similar to those in other mouse studies to to find the lowest effective dose. The study will be conducted on mdx mice, which have a mutated dystrophin gene and are commonly used in DMD research.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
349947
Name
Chen Jinghan Jenny
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Effect of bisphosphonates on muscle in Duchenne muscular dystrophy
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bisphosphonate; Bone; Duchenne Muscular Dystrophy; Mdx; Mouse Model; Muscle; Muscle Damage; Muscle Regeneration; Muscular Dystrophy; Regeneration
Abstract
Duchenne muscular dystrophy (DMD) is a fatal, X-linked recessive disease that affects 1 in 3500 boys. Genetic mutations in the protein dystrophin destabilize the muscle and causes muscle inflammation and degradation. Boys with DMD gradually lose muscle function and become dependent on wheelchairs and ventilators for day-to-day function; they often succumb to the disease in their twenties.In addition to muscle loss, patients also have bone problems, such as fractures. This is due to decreased a lack of physical activity, increased inflammation, and use of drug treatments to retain muscle use. Bisphosphonates (BPs) are given to patients at risk for bone fractures. Previous studies a DMD mouse model found that BP treatment improved muscle strength and decreased markers of muscle degradation; BP-treated mice also have lower markers of ongoing muscle repair, suggesting that fewer muscle fibres were damaged and underwent regeneration. Overall, these observations suggest that BPs are beneficial to muscle in a DMD model. It is unknown how BP treatment is causing such changes, and clarifying its effects can provide new insight into additional treatments for muscle damage.This study will characterize the timeline of BP effects on muscle damage and clarify how BP affects muscle degeneration by histology and gene expression analysis. Pamidronate is chosen as it is effective in pediatric populations. We will use pamidronate doses similar to those in other mouse studies to to find the lowest effective dose. The study will be conducted on mdx mice, which have a mutated dystrophin gene and are commonly used in DMD research.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Chen, Jinghan Jenny
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~